---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-051790"
form_type: "8-K"
ticker: "IOBTQ"
cik: "0001865494"
company_name: "IO Biotech, Inc."
filed_at: "2026-02-13T23:59:59+00:00"
generated_at: "2026-05-16T02:49:52.930637+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# IO Biotech receives Nasdaq MVLS deficiency notice; 180 days to comply

## Summary
- Notice received Feb 12, 2026; MVLS below $50M for 30 consecutive business days.
- Company has until August 11, 2026 to regain compliance.
- Stock continues trading on Nasdaq Global Select Market during cure period.
- If not cured, Nasdaq will issue delisting notice; company may appeal.
- No assurance of regaining compliance with MVLS or other listing rules.

## SEC filing metadata
- accession: 0001193125-26-051790
- form_type: 8-K
- ticker: IOBTQ
- cik: 0001865494
- company_name: IO Biotech, Inc.
- filed_at: 2026-02-13T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1865494/000119312526051790/0001193125-26-051790-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1865494/000119312526051790/d113832d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-051790
- JSON: https://secwatch.observer/filing/0001193125-26-051790.json
- Plain text: https://secwatch.observer/filing/0001193125-26-051790.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.